Recurrent PE risk after long-term warfarin therapy remains high (PADIS-PE)
www.pulmccm.org
Not long ago, doctors were taught that 6 months of anticoagulation was plenty for patients with unprovoked pulmonary embolism. That standard was never based on long-term outcomes studies. And as longer-range data started to come in -- gulp -- it was clear that large numbers of people treated with 6-month warfarin courses after unprovoked PE experienced
Recurrent PE risk after long-term warfarin therapy remains high (PADIS-PE)
Recurrent PE risk after long-term warfarin…
Recurrent PE risk after long-term warfarin therapy remains high (PADIS-PE)
Not long ago, doctors were taught that 6 months of anticoagulation was plenty for patients with unprovoked pulmonary embolism. That standard was never based on long-term outcomes studies. And as longer-range data started to come in -- gulp -- it was clear that large numbers of people treated with 6-month warfarin courses after unprovoked PE experienced